journal article·2016-03-22Open access

Stimuli-Responsive Programmed Specific Targeting in Nanomedicine

Sheng Wang, Peng Huang, Xiaoyuan Chen

ACS Nano· Volume 10· Issue 3

Abstract

Both passive targeting and actively enhanced cellular internalization play significant roles in tumor-targeted therapy. Programmed specific targeting, as a novel targeting strategy that exploits stimuli-responsive structures, expects that nanocarriers show high stability during blood circulation for efficient passive targeting, then respond to tumor internal or external stimuli and transform into more cell-interactive forms upon arrival at the tumor tissue for enhanced cellular internalization. In this Perspective, we introduce recent advances in the design and development of stimuli-responsive programmed specific targeting nanomedicines, which are based on switchable surface charge, activatable targeting molecules, and variable coatings, to combine the advantages of passive targeting and actively enhanced cellular internalization.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoparticle-Based Drug Delivery · Graphene and Nanomaterials Applications · Nanoplatforms for cancer theranostics

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Guangdong Key Laboratory for Biomedical Measurements and Ultrasound Imaging, Department of Biomedical Engineering, School of Medicine, Shenzhen University, Shenzhen 518060, China

Key Laboratory of Optoelectronic Devices and Systems of Ministry of Education and Guangdong Province, College of Optoelectronic Engineering, Shenzhen University, Shenzhen 518060, China

Laboratory of Molecular Imaging and Nanomedicine, National Institute of Biomedical Imaging and Bioengineering, National Institutes of Health, Bethesda, Maryland 20892, United States

Funding

National Institute of Biomedical Imaging and Bioengineering

References (36)

Show source-provided references
1. 10.1038/nnano.2007.38710.1038/nnano.2007.387 ↗
2. 10.1126/science.122633810.1126/science.1226338 ↗
3. 10.1038/nrd259110.1038/nrd2591 ↗
4. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
5. 10.1016/j.jconrel.2010.08.02710.1016/j.jconrel.2010.08.027 ↗
6. 10.1016/S0378-5173(96)04674-110.1016/S0378-5173(96)04674-1 ↗
7. 10.1073/pnas.95.8.460710.1073/pnas.95.8.4607 ↗
8. 10.1021/mp800051m10.1021/mp800051m ↗
9. 10.2217/nnm.10.12210.2217/nnm.10.122 ↗
10. 10.1021/mp900090z10.1021/mp900090z ↗
11. 10.1016/j.ijpharm.2005.10.01010.1016/j.ijpharm.2005.10.010 ↗
12. 10.1021/nn103415x10.1021/nn103415x ↗
13. 10.1002/adma.20140430810.1002/adma.201404308 ↗
14. 10.1073/pnas.080176310510.1073/pnas.0801763105 ↗
15. 10.1021/nn101670k10.1021/nn101670k ↗
16. 10.1021/acsami.5b0451710.1021/acsami.5b04517 ↗
17. 10.1021/ja207150n10.1021/ja207150n ↗
18. 10.1002/anie.20141161510.1002/anie.201411615 ↗
19. 10.1002/smll.20140324810.1002/smll.201403248 ↗
20. 10.1021/ja400127210.1021/ja4001272 ↗
21. 10.1021/nl903411s10.1021/nl903411s ↗
22. 10.1002/anie.20120333910.1002/anie.201203339 ↗
23. 10.1073/pnas.091028310710.1073/pnas.0910283107 ↗
24. 10.1073/pnas.111213210910.1073/pnas.1112132109 ↗
25. 10.1021/acsami.5b0576310.1021/acsami.5b05763 ↗
26. 10.3109/10717544.2011.56731010.3109/10717544.2011.567310 ↗
27. 10.1002/adma.20120095410.1002/adma.201200954 ↗
28. 10.1002/smll.20130192610.1002/smll.201301926 ↗
29. 10.1021/nn300524f10.1021/nn300524f ↗
30. 10.1021/am502579e10.1021/am502579e ↗
31. 10.1021/cr050247k10.1021/cr050247k ↗
32. 10.1038/ncomms436410.1038/ncomms4364 ↗
33. 10.1016/j.semcancer.2008.03.01710.1016/j.semcancer.2008.03.017 ↗
34. 10.1002/adfm.20130322210.1002/adfm.201303222 ↗
35. 10.1016/j.biomaterials.2012.09.02710.1016/j.biomaterials.2012.09.027 ↗
36. 10.1021/nl047998710.1021/nl0479987 ↗